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This study aimed to investigate the association between anomalies in sperm chromatin packaging, morphology
and fertilization in patients undergoing routine in-vrtro fertilization (IVF) or subzonal insemination (SUZI).
Sperm chromatin packaging was assessed using chromomycin A3 (CMA3), a f luorochrome specific for guanine-
cytosine rich sequences of DNA. One hundred to 150 sperm cells were assessed in 55 patients to compare
sperm chromatin packaging and morphology to fertilization after IVF or SUZI. When the morphology and
CMA3 fluorescence of individual spermatozoa was assessed, >75% of the macrocephalic sperm fluoresced in
all patients. In contrast, a mean of 37% of the spermatozoa with normal morphology fluoresced in IVF
patients compared with 58% of the normal spermatozoa in male factor patients treated by SUZI. SUZI
patients displaying a high fluorescence (>70%) in their spermatozoa also had a significantly lower fertilization
rate. Lower packaging quality in morphologically normal spermatozoa may represent a major limiting factor
in the fertilizing ability of male factor patients. This study confirms that a high percentage of CMA3 positivity
is present in certain forms of male factor infertility and that such a test may be used to distinguish separate
populations in morphologically normal spermatozoa.
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Introduction
Semen quality is conventionally determined according to the
number, motility and morphology of spermatozoa in an ejacu-
late (World Health Organization, 1989). In turn, it is generally
accepted that an association exists between these semen
parameters and fertilizing ability (Mahadevan and Trounson,
1984; Kiugeretal, 1986; Liu etal., 1988). Sperm morphology,
in particular, seems to be the most significantly related para-
meter to fertilization rates (Pousette et al, 1986; Oehninger
et al, 1988). With the advent of in-vitro fertilization (TVF)
and related techniques such as subzonal insemination (SUZI)
and intracytoplasmic sperm injection (ICSI), it has become
increasingly apparent that the number, motility and morphology
of spermatozoa are not always indicative of a male's fertility
status. Significantly different fertilization rates have been
reported for patients with similar semen parameters, suggesting
that a more sensitive test is needed to identify the inherent
defects which render certain spermatozoa unable to fertilize
(Jeyendran et al, 1989; Wolf et al, 1992).
A failure of the conventional semen parameters to predict
fertilization indicates that hidden anomalies, lying at the sperm
membrane level or at the chromatin level, should also be
evaluated. A number of studies have shown that spermatozoa
with abnormal nuclear chromatin organization are more fre-
quent in infertile men than in fertile men (Evenson et al,
1980; Monaco and Rasch, 1982; Foresta et al, 1992). In these
studies, specific dyes and fluorochromes were used to assess
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the chromatin of mature mammalian spermatozoa and relate
them to fertilization results. The accessibility of specific dyes
and fluorochromes to DNA can give clues to the packaging
of the chromatin, which occurs during spermiogenesis. How-
ever, the targets of these fluorochromes or dyes vary and may
not be adequate in identifying specific anomalies in chromatin
structure. For example, Monaco and Rasch (1982) compared
DNA fluorochromes specific for GC-rich sequences, mithramy-
cin and chromomycin A3 (CMA3), and for AT-rich sequences,
2'-[4-hydroxyphenyl]-5-[4-methyl-1 -piperazinyl]-2,5'-bi-1H-
benzimidazole and 4-6, diamidino-2-phenylindole. They con-
cluded that, although fluorescence was evident in spermatids
and spermatocytes, a decline in staining with GC-specific
dyes during maturation probably reflected changes in protein
composition and DNA packaging ratios.
In our own studies (Bianchi et al, 1993), we have found
that the amount of protamines present in mature spermatozoa
represented at least one of the limiting factors controlling the
accessibility of CMA3 to the DNA. In the same study we
postulated that the CMA3 fluorochrome could be used as a
tool in routine laboratory analysis for the rapid screening of
certain conditions of subfertility and infertility in man, as it
seemed to allow an indirect visualization of protamine-defi-
cient, nicked and partially denatured DNA. In this study we
investigate the use of CMA3 in relation to individual sperm
morphology. Furthermore, we assess the relationship between
CMA3 fluorescence, in conjunction with morphology, and the
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Table I. Distribution of the semen characteristics in treatmen
in-vitro fertilization (IVF) and subzonal insemination (SUZI)
(a) sperm concentration and motility and (b) morphology
Sperm concentration
(X lO'/ml)
0-5
6-20
>20
Morphology
(% normal forms)
0-20
21-40
>40
Sperm motility (
0-20
IVF SUZI
I 5
0 4
0 1
IVF SUZI"
4 18
17 8
10 2
%)
21-50
IVF
i
0
6
SUZI
6
7
4
t cycles of
according to
>50
IVF
0
2
21
SUZI
2
0
1
Table II. The mean percentage
fluorochrome stain according to
Sperm concentration
(X lO'/ml)
0-5
6-20
>20
Motility (%)
0-20
21-40
>40
of spermatozoa positive to the CMA3
i sperm concentration and motility
No. of
cycles
14
13
34
11
22
28
•Values are means ± SD.
bP < 0.05 compared to 0-5 X 10*/ml sperm concentration
CP < 0.05 compared to 0-20% motility group.
%CMA3
fluorescence*
68.0 + 18.1
59.8 ± 23.0
47.7 ± 16.5b
71.5 ± 20.6
55.4 ±21.8
48.0 ± 15.01
group.
1
 No assessment in two cycles due to insufficient spermatozoa.
outcome of fertilization for patients being treated by routine
IVF and SUZI.
Materials and methods
Patient characteristics and sperm preparation
Semen samples were all taken from 55 patients undergoing treatment
for infertility at the Clinic for Infertility and Gynaecological Endo-
crinology-WHO Collaborating Centre, University Hospital of Geneva,
Geneva, Switzerland. Ejaculated human spermatozoa were collected
and the greater part prepared for routine IVF or SUZI. The criteria
for selection of patients performing either procedure was: for IVF,
an insemination droplet of at least 100 000 motile spermatozoa could
be prepared, and for SUZI, < 100 000 motile spermatozoa after
preparation or patients having failed to achieve fertilization in at least
two previous IVF attempts. Table I shows the semen characteristics
for the 55 patients (61 cycles) making up the IVF and SUZI groups.
Morphology was assessed according to World Health Organization
criteria (1989) and progressive motility by visual appraisal using a
Makler chamber.
FVF and SUZJ were performed using the stimulation protocol and
procedures previously published (Umer et al., 1993; Sakkas el al.,
1994). Spermatozoa were prepared for both techniques by treating
the sample with 3 mM pentoxifylline (Sigma Pharmaceuticals, Buchs,
Switzerland) followed by selection using mini-Percoll gradient centri-
fugation (Ord et al, 1990). From the remains of the semen sample,
one slide was prepared for assessment of sperm morphology while
the rest was washed in Dulbecco's Ca2+-Mg2+ free phosphate-
buffered saline (PBS) and centrifuged at 170 g for 10 min. The
procedure was repeated twice and the washed spermatozoa were fixed
in methanol/glacial acetic acid 3:1, at 4°C, for 5 min and then spread
on slides.
Chromomycln A3 staining and assessment of sperm mor-
phology
For CMA3 (Sigma) staining, each slide was treated for 20 min with
100 nl of CMA3 solution (0.25 mg/ml in Mcllvane buffer, pH 7.0,
containing 10 mM MgCli)- Slides were then rinsed in buffer and
mounted with buffered glycerol. Fluorescence was performed using
a Zeiss Photomikroskop HI using a combination of exciter: dichroic:
barrier niters of BP 436710: FT 580: LP 470 and an A-Plan X20
objective lens. This lens allowed the use of both phase and fluores-
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cence. For each patient, a total of 100-150 spermatozoa were randomly
observed on duplicate slides. For each single spermatozoon, head
morphology (divided in three categories: normal, macrocephalic or
amorphous) and fluorescence were assessed.
Statistical analysis
The means in the different groups were transformed using an arcsin
square root transformation and compared for statistical significance
using one-way analysis of variance and Scheffe's F-test. A test of
the correlation between the percentage of spermatozoa positive to the
CMA3 fluorochrome and head morphology per patient was performed
using regression analysis.
Results
Chromomycin A3 positivity in relation to sperm con-
centration, motility and morphology
Sperm concentration and motility
The mean percentage of spermatozoa fluorescent after CMA3
treatment declined in relation to increased sperm concentration
and motility (Table H). Patients with severe oligozoospermia
or asthenozoospermia had a mean (±SD) of 68.0 ± 18.0% and
71.5 ± 20.6% of their spermatozoa fluorescing respectively. A
distinct decline in spermatozoa quality was therefore associated
with CMA3 fluorescence.
Morphology
Although a decline in sperm number and motility was associa-
ted with increased CMA3 fluorescence, a comparison of CMA3
positivity and morphology in individual spermatozoa showed
that apparently normal spermatozoa may possess hidden
anomalies. By observing fluorescence and morphology in
single sperm heads from the two groups of patients, we found
that in all samples >75% of the spermatozoa displaying
macrocephaly fluoresced brightly while ~50% of the spermato-
zoa classed as having an amorphous head shape fluoresced
(Figure 1). The main difference between the treatment groups
was seen in spermatozoa classed as having a normal shape. In
patients undergoing routine IVF, a mean (±SD) of 38.2 ±
19.2% of the morphologically normal spermatozoa fluoresced
while in the male factor patients treated by SUZI 57.8 ±
27.4% fluoresced; this was significant (P < 0.05). In nine
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out of 30 samples from male factor patients, >80% of all
spermatozoa were fluorescent compared with only one of the
FVF samples.
There was no correlation between the percentage of
spermatozoa with abnormal head morphology and the percent-
age of spermatozoa showing fluorescence after CMA3 staining
(Figure 2). Therefore, although macrocephalic spermatozoa
were nearly always fluorescent, spermatozoa with amorphous
and normal heads vary in chromatin packaging. Samples
macro amorphous normal macro amorphous normal
cephalic cephalic
<73.J±14.7) (48.0±16.2) (38-2±19.2>* <79.2±M.2) (56.4£l9.8> <57.8±27.-)>»
Figure 1. A box plot comparing the different types of sperm
morphology to the percentage of spermatozoa positive to the
chromomycin A3 (CMA3) fluorochrome. The lower 25th and upper
75th percentiles are shown. Two groups are represented,
normozoospermic patients (n = 31) treated by routine in-vitro
fertilization (IVF, open) and male factor patients (n = 30) treated
by subzonal insemination (SUZI, shaded). Individual spermatozoa
were assessed for both morphology and CMA3 fluorescence. The
mean (± SD) percentage of spermatozoa positive for CMA3
fluorescence in each group is given in parentheses. *Percentage of
spermatozoa with normal morphology and positive for CMA3
fluorescence was significantly different (P < 0.05) in samples from
the IVF and SUZI groups of patients.
prepared from the same ejaculate and evaluated independently
gave r values of 0.36 and 0.41 when comparing percentage of
cells with abnormal head morphology and showing CMA3
fluorescence for the IVF and SUZI patients respectively
(Figure 2).
Chromomycin A3 positivity in relation to fertilization,
cleavage rates and pregnancy
In-vitro fertilization
There was no association between CMA3 fluorescence in all
spermatozoa and fertilizing ability for patients being treated
by routine IVF (data not shown). In seven cases where patients
had <20% fertilization rates there was no difference in
positivity of sperm to the CMA3 fluorochrome when compared
to cases with fertilization rates >20%. As in routine IVF there
is a greater competition between spermatozoa, it could be
expected that a motile morphologically normal spermatozoon
would fertilize the oocyte. However, no relationship was
found between fertilizing ability and CMA3 fluorescence in
morphologically normal spermatozoa in patients treated by
routine IVF.
Subzonal insemination
In contrast to the lack of an association in IVF patients, male
factor patients treated by SUZI had a significantly lower
mean fertilization rate when their spermatozoa showed a high
positivity to the CMA3 fluorochrome. Ten SUZI patients had
>70% of spermatozoa positive to the CMA3 fluorochrome
and had a significantly lower (P < 0.02) fertilization rate;
CMA3 of >70%: 24.9 ± 15.9 compared with CMA3 of <70%:
55.7 ± 26.3. The same 10 patients also had >70% fluorescence
in their morphologically normal spermatozoa, which was
indicative of poor fertilizing ability when using SUZI
(Table IH).
Embryo cleavage and pregnancies
Once fertilization had occurred, there was no relationship
between the ability of a fertilized oocyte to cleave and positivity
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Figure 2. Correlation between the percentages of spermatozoa with abnormal head morphology and spermatozoa positive to the
chromomycin A3 (CMA3) fluorochrome. Regression equations are given for the normozoospermic patients (n = 31) treated by routine
in-vitro fertilization (IVF) and male factor patients {n = 30) treated by subzonal insemination (SUZI).
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Table III. Mean fertilization rate of sperm samples from men treated by
subzonal insemination (SUZI) in relation to positivity of morphologically
normal spermatozoa to the CMA3 fluorochrome
Percentage of morphologically No. of
normal sperm fluorescing cases1
Mean fertilization
rate"
0-50
50-70
> 70
10
7
10
56.4 ± 25.2
53.6 ± 30.2
24.9 ±
"Only cases which had more than four oocytes treated were included.
bValues are means ± SD.
CP < 0.02 compared to the 0-50 and 50-70 groups.
to the CMA3 fluorochrome in either treatment group. Five of
the 31 IVF cycles resulted in ongoing pregnancies; of the
five pregnancies, four of the male partners showed CMA3
fluorescence values of 20-40%, while one male had 86% of
his spermatozoa fluorescing after CMA3 staining. In the two
ongoing pregnancies from the 30 SUZI cycles, the CMA3
fluorescence was 62 and 77%. Although the numbers are
limited, the results suggest that CMA3 positivity is not related
to embryo viability.
Discussion
One of the central events of spermiogenesis is the substitution
of the chromatin structural proteins by protamines, allowing a
different structural organization to take place in the sperm
nucleus (Courtens and Loir, 1981; Balhom, 1989; Ward and
Coffey, 1991). Indeed, as reviewed by Ward and Coffey (1991),
chromatin packaging in spermatozoa is very different from
that of somatic cells; for example, the mouse sperm cell
nucleus is 40-fold smaller than the nucleus of the mouse
somatic cell. Due to the tight packaging afforded by the
protamines, any modification or absence of these proteins
could lead to an anomaly in the packaging process of sperm
nuclei and influence sperm quality and fertilizing capacity.
The different models proposed for the binding of protamines
to DNA in spermatozoa (Balhom, 1982; Subirana, 1991)
postulate that the polyarginine segment of protamine binds in
the minor groove of DNA, cross-linking and neutralizing the
phosphodiester backbone. The CMA3 fluorochrome is also
believed to access DNA in the minor groove of the DNA helix
(Behietal, 1969; Berman etal., 1985), a positional preference
that can make it a competitor to protamines. CMA3 has
previously been shown to be a useful tool to indicate protamine-
depleted spermatozoa (Bianchi et al, 1993). In contrast to the
homogeneity of mature mouse spermatozoa, ejaculated human
spermatozoa samples were found to exhibit a wide variation
both in their responsiveness to the CMA3 fluorochrome and
in the presence of endogenous nicks in the DNA (Bianchi
et al, 1993; Sakkas et al., 1995).
Treatment of human sperm samples with protamines elimin-
ates CMA3 positivity and prevents the identification of endo-
genous DNA nicks by in-situ nick translation, a technique that
reveals damaged DNA (Bianchi et al, 1993; Manicardi et al,
1995). We have now investigated the relationship between
CMA3 positivity and fertilizing capacity in spermatozoa from
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two populations of patients undergoing IVF and SUZI treatment
and found interesting differences in respect to their response
to the CMA3 fluorochrome. In this study we show that the
CMA3 fluorescence provides evidence of: (i) a population of
spermatozoa that exhibit normal head morphology but possess
loosely packaged chromatin; and (ii) a positive correlation
between fertilization failure and CMA3 fluorescence in morpho-
logically normal spermatozoa in the SUZI treatment, and not
in the routine IVF group. Such a difference is most likely
related to the different methods of achieving fertilization. In
routine IVF, sperm competition is maximal due to the excess
number of spermatozoa used; therefore even in patients with
a high CMA3 positivity enough normal sperm should be
present to achieve fertilization. In contrast, in semen samples
selected for SUZI, where the number of spermatozoa in contact
with the oocyte is limited, a high CMA3 positivity yields a
lower chance of achieving fertilization due to the lower
probability of selecting a normal spermatozoon.
To this day, sperm quality has mainly been judged by
parameters such as number, motility, and morphology. The
influence of seminal parameters as a whole or individually on
fertility has been a matter of investigation and discussion since
the early days of infertility treatment. Literature on the subject
is contradictory and results can vary extensively according to
methodology of analysis, dyes utilised, interpretation criteria
of morphology and technology available. Nonetheless, Bestoffe
etal. (1982), showed an inverse correlation between percentage
of abnormal sperm forms and spontaneous pregnancies in a
retrospective study in subfertile couples. This debate has gained
new vitality since the new assisted reproduction technologies
provided a much more precise tool for evaluation of fertilization
rates. Although a proper consensus has not yet been established,
it has become widely accepted that normal parameters, defined
according to WHO criteria (1989) are associated with high
percentages of fertilization and cleavage rates in IVF. Further-
more, many authors have concentrated their attention on the
predictive value of morphology (Kruger et al, 1986; Pousette
et al, 1986), and it is felt that normal morphology is indicative
of normal function, while high levels of morphologically
abnormal spermatozoa in the ejaculate are associated with a
reduced fertilizing potential (Oehninger et al, 1988). When
we compared the morphology and CMA3 fluorescence in
individual spermatozoa, we found a high frequency of CMA3
positive nuclei among macrocephalic spermatozoa in both
treatment groups. This confirms data known on other fluores-
cent dyes, in particular Acridine Orange, where access to the
DNA was achieved only or mostly in cases of decondensed
or damaged chromatin (Evenson et al, 1980; 1991; Foresta
et al, 1992; Molina et al, 1995; Sailer et al, 1995). Our
observations also confirm that macrocephaly is associated with
decondensation. Moreover, this is further evidence of the
protamine-depleted status of macrocephalic spermatozoa, as
CMA3 is unable to access DNA in the presence of protamines
and normally formed disulphide bonds (Bianchi et al, 1993;
Kvist, 1982). The fact that fluorescence was still present in
the 'amorphous' category but was reduced to 50% probably
reflects the fact that this group contained several, and probably
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very different head defects, not all of which correspond to a
decondensed status of the nuclear chromatin.
In our opinion the most interesting result was the statistically
significant difference in fluorescence of normal spermatozoa
between the two groups examined, casting a shadow on the
value of assessing normal morphology, particularly in the
cases of oligoasthenoteratozoospermia (OAT). As proposed by
Bartoov et al. (1994) such patients may require a more
complete sperm evaluation, as normal forms observed by light
microscopy do not fully express the anatomical capability
hidden in the sperm morphology. Engh et al. (1992) also
found in a cytofluorimetrical evaluation of 100 male patients
undergoing investigations because of infertility that patients
with severe OAT presented a higher percentage of fluorescent
cells in comparison with normozoospermic patients. Our data
confirm this in situ with a direct comparison, per individual
cell, of fluorescence and morphology. Interestingly, one third
of the samples of SUZI patients (usually patients with OAT)
presented >80% of fluorescent cells, while only one out of
31 of the FVF patients presented the same features. This
suggests that the difference does not only rely on a decrease
of the classical sperm parameters but on a defect in the
packaging of chromatin, which can affect all the spermatozoa
produced by testicular germinal tissue.
This highlights the importance of detecting this population
of patients prior to treatment by IVF, as a spermatozoon
possessing decondensed chromatin may be unable to achieve
syngamy, even upon penetration of the oolemma membrane.
When we compared the results of fluorescence to fertilizing
capacity in the SUZI patients, we found data to reinforce this
hypothesis, as the fertilization rate declines to nearly 20%
when a very high number of spermatozoa are fluorescent, a
situation that could be taken into account when deciding
upon treatment. The fact that cleavage rate is apparently not
influenced confirms that the crucial moment is at intra-oocyte
decondensation and/or disturbances in its occurrence with all
the subsequent processes such as protamine elimination and
substitution by histones. Although this result has been observed
using the SUZI technique, its relevance to the use of intracyto-
plasmic sperm injection (ICSI) as a treatment of male factor
infertility awaits resolution.
The results from this study suggest that CMA3 could become
a useful tool for evaluation of male factor patients prior
to infertility treatment. CMA3 will distinguish decondensed,
protamine-depleted spermatozoa. Moreover, CMA3 is also
useful in identifying DNA-damaged sperm cells as shown by
the presence of endogenous nicks in many decondensed CMA3
positive nuclei (Manicardi et ai, 1995). This would make it
possible to screen for those patients whose spermiogenesis has
resulted in a sperm population containing intrinsic anomalies
in the nuclei, regardless of sperm morphology.
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